Regina Nanieva

Papers

Total Citations

H-Index

About

Regina Nanieva is a distinguished urological researcher whose work centers on advanced therapeutic interventions for prostate cancer, particularly in the challenging context of hormone-resistant disease. Her primary research focus lies in the application of High-Intensity Focused Ultrasound (HIFU) as a minimally invasive treatment modality, with a specific emphasis on robotic-assisted delivery systems. Nanieva’s most cited work, "Hormon Resistant Prostate Cancer Treated by Robotic High Intensive Ultrasound," published in the Journal of Urology in 2010, represents a pivotal contribution to the field. This study, co-authored with pioneers Christian Chaussy and Stefan Thueroff, demonstrated the feasibility and potential efficacy of robotic HIFU in treating patients with castration-resistant prostate cancer—a population with historically limited therapeutic options. While her citation count of 3 reflects the niche and highly specialized nature of this early work, its significance lies in laying foundational clinical evidence for a technology that has since evolved into a standard option for focal therapy. Nanieva’s research bridges the gap between engineering innovation and oncological urology, offering patients a non-invasive alternative to radical surgery or radiation. Her contributions continue to inform ongoing developments in targeted ultrasound ablation for resistant disease.